Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL.
暂无分享,去创建一个
P. A. Futreal | Z. Estrov | H. Kantarjian | Koichi Takahashi | N. Daver | M. Keating | S. O'brien | J. Burger | N. Jain | C. Peterson | W. Wierda | A. Ferrajoli | P. Strati | P. Thompson | P. Futreal